Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannae Holdings is a diversified holding company that manages a portfolio of market-leading businesses, with a significant strategic focus on the healthcare and medical technology sectors. The company's healthcare presence is primarily defined by its majority ownership of Corza Medical, a global provider of surgical technologies including sutures, ophthalmic instruments, and advanced biosurgery products like the TachoSil fibrin sealant patch. Additionally, Cannae holds a substantial interest in AmeriLife, a leader in the distribution of health and life insurance products for the senior market. Led by Chairman William P. Foley II, the firm employs an active management approach to drive operational improvements and long-term capital appreciation across its investments. Cannae's portfolio also spans financial services and technology, providing a broad base of industrial expertise. The company is publicly traded on the New York Stock Exchange under the symbol CNNE.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannae Holdings.